UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053381
Receipt number R000060916
Scientific Title Serum albumin levels in patients hospitalized for proximal femur fractures
Date of disclosure of the study information 2024/01/19
Last modified on 2024/04/19 19:16:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Serum albumin levels in patients hospitalized for proximal femur fractures

Acronym

N. A.

Scientific Title

Serum albumin levels in patients hospitalized for proximal femur fractures

Scientific Title:Acronym

N. A.

Region

Japan


Condition

Condition

Proximal femur fractures

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Many patients with proximal femur fractures are undernourished before the injury and complications are exacerbated by the surgical invasion, affecting prognosis, but in addition to preoperative undernutrition, postoperative undernutrition has also been reported to have an impact on life expectancy. Thus, although undernutrition is a risk factor for death and other conditions, these associated factors have not been investigated. In addition, compared to patients at home, institutionalized patients are considered a poor prognostic factor, and institutionalized patients with proximal femur fractures have brought in low nutrition, which may lead to a poor prognosis. In addition, there is a paucity of studies on nutrition in patients admitted with proximal femur fractures in which dieticians intervened. Identification of factors associated with the nutritional status of orthopaedic patients admitted with proximal femur fractures could lead to advances in nutritional guidance and improved prognosis for such patients. The aim of this study was therefore to examine the nutritional status of patients admitted with a proximal femur fracture using a retrospective observational study design.

Basic objectives2

Others

Basic objectives -Others

Risk assessment

Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Serum albumin levels on admission

Key secondary outcomes

Secondary endpoints are admission, during hospitalization and outcome.
Survey items include age, gender, current medical history, medical history (underlying disease), smoking, medication, housing, use of long-term care insurance schemes, height, weight, whole blood (red blood cell count, hemoglobin level, hematocrit level, white blood cell count, total lymphocyte count), serum CRP level, serum total protein level, serum albumin level, serum transthyretin level, serum total cholesterol level, serum triglyceride level, serum HDL cholesterol level, serum LDL cholesterol level, serum urea nitrogen level, serum creatinine level, serum eGFR level, serum Bil level, serum AST level, serum ALT level, serum ALP level, serum GTP level, serum sodium ion concentration, serum potassium ion concentration, serum chloride ion concentration, serum calcium ion concentration, serum phosphorus concentration, GNRI, PNI, CONUT, rehabilitation intervention, nutrition support team intervention, dietary intake, nutritional intake, independence in daily living, activities of daily living, walking ability, intelligence rating scale values, bedsore ulcers, fracture type, days to surgery, operative technique, operative time, intra-operative blood loss, days to start training, post-operative complications, length of stay in hospital and discharge destination.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients hospitalized with proximal femur fracture at the NHO Kyoto Medical Center.

Key exclusion criteria

Age less than 65 years at the time of enrollment.
Serum albumin level is missing/
Proximal femur fracture caused by high-energy trauma.
Patients who were transferred to another hospital after sustaining a fracture of the femoral neck while hospitalized at another hospital.
Patients who were COVID-19 positive from the time of admission.

Target sample size

250


Research contact person

Name of lead principal investigator

1st name Ami
Middle name
Last name Takahashi

Organization

Doshisha Women's College Graduate School of Liberal Arts

Division name

Human Life and Science

Zip code

602-8580

Address

Teramachi-nishiiru, Imadegawa-dori, Kamigyo-ku, Kyoto 602-0893, Japan

TEL

075-251-4211

Email

is23006@dwc.doshisha.ac.jp


Public contact

Name of contact person

1st name Ami
Middle name
Last name Takahashi

Organization

Doshisha Women's College Graduate School of Liberal Arts

Division name

Human Life and Science

Zip code

602-8580

Address

Teramachi-nishiiru, Imadegawa-dori, Kamigyo-ku, Kyoto 602-0893, Japan

TEL

075-251-4111

Homepage URL


Email

is23006@dwc.doshisha.ac.jp


Sponsor or person

Institute

Doshisha Women's College Graduate School of Liberal Arts

Institute

Department

Personal name

Takahashi Ami


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

NHO Kyoto Medical Center

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee on Research Involving Human Subjects, Doshisha Women's University

Address

97-1 Okidominamihokotachi, Kyotanabe, Japan

Tel

0774-65-8679

Email

reserch@dwc.doshisha.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

同志社女子大学(Dosisha Women’s College)、国立病院機構京都医療センター (NHO Kyoto Medical Center)


Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 11 Month 01 Day

Date of IRB

2023 Year 11 Month 16 Day

Anticipated trial start date

2024 Year 01 Month 19 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Primary endpoint is Serum albumin levels on admission.
Secondary endpoints are admission, during hospitalization and outcome.
Survey items include age, gender, current medical history, medical history (underlying disease), smoking, medication, housing, use of long-term care insurance schemes, height, weight, whole blood (red blood cell count, hemoglobin level, hematocrit level, white blood cell count, total lymphocyte count), serum CRP level, serum total protein level, serum albumin level, serum transthyretin level, serum total cholesterol level, serum triglyceride level, serum HDL cholesterol level, serum LDL cholesterol level, serum urea nitrogen level, serum creatinine level, serum eGFR level, serum Bil level, serum AST level, serum ALT level, serum ALP level, serum GTP level, serum sodium ion concentration, serum potassium ion concentration, serum chloride ion concentration, serum calcium ion concentration, serum phosphorus concentration, GNRI, PNI, CONUT, rehabilitation intervention, nutrition support team intervention, dietary intake, nutritional intake, independence in daily living, activities of daily living, walking ability, intelligence rating scale values, bedsore ulcers, fracture type, days to surgery, operative technique, operative time, intra-operative blood loss, days to start training, post-operative complications, length of stay in hospital and discharge destination.


Management information

Registered date

2024 Year 01 Month 17 Day

Last modified on

2024 Year 04 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060916


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name